Mekanisk perfusion - experimentella och kliniska FoU i

Neurological and general outcome in low-risk coronary artery

The CBAS Heparin Surface stays on the surface and remains bioactive on the EXCOR pump at least up until 1 year. This is an important demonstration of coating durability and supports the mid-term and long-term clinical use as bridge-to-heart transplantation or to myocardial recovery. The luminal surface of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive is modified with a covalently bound, bioactive heparin technology referred to as the Carmeda BioActive Surface (CBAS®). Figure 1: The GORE® VIABAHN® Endoprosthesis . External Nitinol Stent ePTFE Lining One of the most clinically successful heparin technologies has been the Carmeda® BioActive Surface (CBAS). 12, 13 This heparin binding technology is based upon covalent end-point attachment of heparin to a biomaterial surface, enabling maintenance of functional heparin bioactivity. The selection ranges from bioinert or biopassive modification strategies -also in combination with adjusted microstructure and topography, via bioactive and biomimetic modification techniques to endothelial cells (ECs) as biological surface coatings and gene therapeutic approaches.

Se hela profilen på LinkedIn, se Lovisas kontakter och Structuring of surface-active macromolecules. M Hedhammar, L Scalable Synthesis of Monodisperse Bioactive Spider Silk Nanostrucutres. L Gustafsson, WN Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps. Referentgranskad. DOI10.1097/MAT.0000000000000314. Östberg, G, et al.

European Journal of Vascular & Endovascular Surgery 2003;25(5):432-437. Freeman J, Chen A, Weinberg RJ, Okada T, Chen C, Lin PH. Because of its extensive publication history, there is emphasis on the CARMEDA ® BioActive Surface (CBAS ® Heparin Surface), a widely used commercialized technology for the covalent bonding of heparin.

MCS, Excore - Omvårdnadsrutin och teknisk - Alfresco

Below is a selection of currently approved products featuring the Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps. Artikel i vetenskaplig tidskrift, refereegranskad. Författare. Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps.

Carmeda AB - Företagsinformation - Allabolag

This is an important demonstration of coating durability and supports the mid-term and long-term clinical use as bridge-to-heart transplantation or to myocardial recovery. In the following experiments, we evaluated the heparin-bonded Carmeda Bioactive Surface (Medtronics Cardiopulmonary, Anaheim, Calif.) in an in vitro model of extracorporeal circulation at standard-dose heparin (5 U/ml), to examine the effects of the surface treatment on activation of blood elements, and at reduced-dose heparin (1 U/ml), to determine whether surface-bound heparin would serve as an effective anticoagulant. The CBAS Heparin Surface stays on the surface and remains bioactive on the EXCOR pump at least up until 1 year.

MEDTRONIC PERFUSION SYSTEMS [MEDTRONIC INC.] Affinity Fusion Oxygenator with Integrated Arterial Filter and Carmeda BioActive Surface, 2017- 12-07. The CARMEDA® BioActive Surface is a clinically proven and lasting thromboresistant heparin coating that actively prevents platelet adhesion and thrombus The CARMEDA® BioActive Surface is licensed to major medical device companies worldwide. Below is a selection of currently approved products featuring the Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps.
Johan henriksson umeå

Biocompatible surface with bioactive binding sites for enhanced cell adhesion Synthetic polymers can provide sufficient mechanical strength in vascular graft construction, but inadequate bioactivity since lacking sufficient cellular recognition sites for cell adhesion [ 102 ]. Carmeda. Carmeda is a medical coating company that develops, manufactures, and markets biocompatible coating technologies.

The CARMEDA® BioActive Surface is a clinically proven and lasting thromboresistant heparin coating that actively prevents platelet adhesion and thrombus The CARMEDA® BioActive Surface is licensed to major medical device companies worldwide. Below is a selection of currently approved products featuring the Clinical Durability of the CARMEDA BioActive Surface in EXCOR Ventricular Assist Device Pumps. Artikel i vetenskaplig tidskrift, refereegranskad. Författare.
Mobilreparation kungsgatan stockholm

mina sidor a kassa
självförsvar skjutvapen
ett minne från min barndom
flanellskjorta engelska
ica gnesta jobb

Styrelse och företagsledning - Cision

Hållbart företagande mittuniversitetet
nok eur index

swepub - SwePub - sökning

CCS Circuit with Continuous A-V Loop, Bridge Adaptor, Bio-Pump, Flow Probe, Affinity™ CB511 Oxygenator and Accessory Package The CARMEDA ® BioActive Surface is a heparin-based coating designed to actively reduce thrombus formation on blood contacting medical devices. It is the most clinically proven thromboresistant surface coating available on the market.